221 related articles for article (PubMed ID: 28314930)
21. The efficacy of uracil DNA glycosylase pretreatment in amplicon-based massively parallel sequencing with DNA extracted from archived formalin-fixed paraffin-embedded esophageal cancer tissues.
Serizawa M; Yokota T; Hosokawa A; Kusafuka K; Sugiyama T; Tsubosa Y; Yasui H; Nakajima T; Koh Y
Cancer Genet; 2015 Sep; 208(9):415-27. PubMed ID: 26194062
[TBL] [Abstract][Full Text] [Related]
22. Bioinformatics and DNA-extraction strategies to reliably detect genetic variants from FFPE breast tissue samples.
Bhagwate AV; Liu Y; Winham SJ; McDonough SJ; Stallings-Mann ML; Heinzen EP; Davila JI; Vierkant RA; Hoskin TL; Frost M; Carter JM; Radisky DC; Cunningham JM; Degnim AC; Wang C
BMC Genomics; 2019 Sep; 20(1):689. PubMed ID: 31477010
[TBL] [Abstract][Full Text] [Related]
23. KLF6 and TP53 mutations are a rare event in prostate cancer: distinguishing between Taq polymerase artifacts and true mutations.
Agell L; Hernández S; de Muga S; Lorente JA; Juanpere N; Esgueva R; Serrano S; Gelabert A; Lloreta J
Mod Pathol; 2008 Dec; 21(12):1470-8. PubMed ID: 19020536
[TBL] [Abstract][Full Text] [Related]
24. Why Formalin-fixed, Paraffin-embedded Biospecimens Must Be Used in Genomic Medicine: An Evidence-based Review and Conclusion.
Mathieson W; Thomas GA
J Histochem Cytochem; 2020 Aug; 68(8):543-552. PubMed ID: 32697619
[TBL] [Abstract][Full Text] [Related]
25. HaloPlex Targeted Resequencing for Mutation Detection in Clinical Formalin-Fixed, Paraffin-Embedded Tumor Samples.
Moens LN; Falk-Sörqvist E; Ljungström V; Mattsson J; Sundström M; La Fleur L; Mathot L; Micke P; Nilsson M; Botling J
J Mol Diagn; 2015 Nov; 17(6):729-39. PubMed ID: 26354930
[TBL] [Abstract][Full Text] [Related]
26. DEEPOMICS FFPE, a deep neural network model, identifies DNA sequencing artifacts from formalin fixed paraffin embedded tissue with high accuracy.
Heo DH; Kim I; Seo H; Kim SG; Kim M; Park J; Park H; Kang S; Kim J; Paik S; Hong SE
Sci Rep; 2024 Jan; 14(1):2559. PubMed ID: 38297116
[TBL] [Abstract][Full Text] [Related]
27. Somatic Mutation Screening Using Archival Formalin-Fixed, Paraffin-Embedded Tissues by Fluidigm Multiplex PCR and Illumina Sequencing.
Wang M; Escudero-Ibarz L; Moody S; Zeng N; Clipson A; Huang Y; Xue X; Grigoropoulos NF; Barrans S; Worrillow L; Forshew T; Su J; Firth A; Martin H; Jack A; Brugger K; Du MQ
J Mol Diagn; 2015 Sep; 17(5):521-32. PubMed ID: 26165823
[TBL] [Abstract][Full Text] [Related]
28. Identification of patients with (atypical) MUTYH-associated polyposis by KRAS2 c.34G > T prescreening followed by MUTYH hotspot analysis in formalin-fixed paraffin-embedded tissue.
van Puijenbroek M; Nielsen M; Tops CM; Halfwerk H; Vasen HF; Weiss MM; van Wezel T; Hes FJ; Morreau H
Clin Cancer Res; 2008 Jan; 14(1):139-42. PubMed ID: 18172263
[TBL] [Abstract][Full Text] [Related]
29. Whole exome sequencing (WES) on formalin-fixed, paraffin-embedded (FFPE) tumor tissue in gastrointestinal stromal tumors (GIST).
Astolfi A; Urbini M; Indio V; Nannini M; Genovese CG; Santini D; Saponara M; Mandrioli A; Ercolani G; Brandi G; Biasco G; Pantaleo MA
BMC Genomics; 2015 Nov; 16():892. PubMed ID: 26531060
[TBL] [Abstract][Full Text] [Related]
30. Use of the QIAGEN GeneReader NGS system for detection of KRAS mutations, validated by the QIAGEN Therascreen PCR kit and alternative NGS platform.
Darwanto A; Hein AM; Strauss S; Kong Y; Sheridan A; Richards D; Lader E; Ngowe M; Pelletier T; Adams D; Ricker A; Patel N; Kühne A; Hughes S; Shiffman D; Zimmermann D; Te Kaat K; Rothmann T
BMC Cancer; 2017 May; 17(1):358. PubMed ID: 28532404
[TBL] [Abstract][Full Text] [Related]
31. Detection of KRAS codon 12 and 13 mutations by mutant-enriched PCR assay.
Chang YS; Er TK; Lu HC; Yeh KT; Chang JG
Clin Chim Acta; 2014 Sep; 436():169-75. PubMed ID: 24863805
[TBL] [Abstract][Full Text] [Related]
32. Towards standardization of next-generation sequencing of FFPE samples for clinical oncology: intrinsic obstacles and possible solutions.
Ivanov M; Laktionov K; Breder V; Chernenko P; Novikova E; Telysheva E; Musienko S; Baranova A; Mileyko V
J Transl Med; 2017 Jan; 15(1):22. PubMed ID: 28137276
[TBL] [Abstract][Full Text] [Related]
33. Automation of genomic DNA isolation from formalin-fixed, paraffin-embedded tissues.
Sam SS; Lebel KA; Bissaillon CL; Tafe LJ; Tsongalis GJ; Lefferts JA
Pathol Res Pract; 2012 Dec; 208(12):705-7. PubMed ID: 23057998
[TBL] [Abstract][Full Text] [Related]
34. Limited copy number-high resolution melting (LCN-HRM) enables the detection and identification by sequencing of low level mutations in cancer biopsies.
Do H; Dobrovic A
Mol Cancer; 2009 Oct; 8():82. PubMed ID: 19811662
[TBL] [Abstract][Full Text] [Related]
35. A streamlined method for analysing genome-wide DNA methylation patterns from low amounts of FFPE DNA.
Ludgate JL; Wright J; Stockwell PA; Morison IM; Eccles MR; Chatterjee A
BMC Med Genomics; 2017 Aug; 10(1):54. PubMed ID: 28859641
[TBL] [Abstract][Full Text] [Related]
36. The importance of evaluation of DNA amplificability in KRAS mutation testing with dideoxy sequencing using formalin-fixed and paraffin-embedded colorectal cancer tissues.
Okayama N; Nishioka M; Hazama S; Sakai K; Suehiro Y; Maekawa M; Sakamoto J; Iwamoto S; Kato T; Mishima H; Oka M; Hinoda Y
Jpn J Clin Oncol; 2011 Feb; 41(2):165-71. PubMed ID: 20926413
[TBL] [Abstract][Full Text] [Related]
37. Accuracy of BRCA1 and BRCA2 founder mutation analysis in formalin-fixed and paraffin-embedded (FFPE) tissue.
Adank MA; Brogi E; Bogomolniy F; Wadsworth EA; Lafaro KJ; Yee CJ; Kirchhoff T; Meijers-Heijboer EJ; Kauff ND; Boyd J; Offit K
Fam Cancer; 2006; 5(4):337-42. PubMed ID: 16724247
[TBL] [Abstract][Full Text] [Related]
38. Mutation screening using formalin-fixed paraffin-embedded tissues: a stratified approach according to DNA quality.
Cucco F; Clipson A; Kennedy H; Sneath Thompson J; Wang M; Barrans S; van Hoppe M; Ochoa Ruiz E; Caddy J; Hamid D; Cummin T; Burton C; Davies AJ; Johnson P; Du MQ
Lab Invest; 2018 Aug; 98(8):1084-1092. PubMed ID: 29769698
[TBL] [Abstract][Full Text] [Related]
39. Time and tumor type (primary or metastatic) do not influence the detection of BRAF/NRAS mutations in formalin fixed paraffin embedded samples from melanomas.
Potrony M; Badenas C; Naerhuyzen B; Aguilera P; Puig-Butille JA; Tell-Marti G; Díaz A; Carrera C; Alos L; Delahaye N; Malvehy J; Puig S
Clin Chem Lab Med; 2016 Nov; 54(11):1733-1738. PubMed ID: 27101548
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of BRAF mutation testing methodologies in formalin-fixed, paraffin-embedded cutaneous melanomas.
Lade-Keller J; Rømer KM; Guldberg P; Riber-Hansen R; Hansen LL; Steiniche T; Hager H; Kristensen LS
J Mol Diagn; 2013 Jan; 15(1):70-80. PubMed ID: 23159593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
